Joint Position Statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on Routine Testing for Latent Tuberculosis Infection Prior To and During Treatment of Psoriasis Patients with IL-17 or IL-23 Inhibitors
Related Posts
Taghizadeh CS, Goh C, Lipner SR. Ethical Considerations of Excusing Students With Alopecia Areata From Physical Education Activities. J Am Acad Dermatol. 2026 Mar 20:S0190-9622(26)00455-X.[...]
Kasperkiewicz M, Thapa M, Adotama P, Tomayko MM, Culton DA. US expert opinions on the treatment of bullous pemphigoid based on guidelines from the European[...]
Jiang R, Bogle R, Xing X, Kirma J, Fox J, Harms PW, Do T, Billi AC, Kahlenberg JM, Modlin RL, Teles R, West J, Mangold[...]